+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanotechnology in Drug Delivery - Global Strategic Business Report

  • PDF Icon

    Report

  • 272 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2769238
The global market for Nanotechnology in Drug Delivery is estimated at US$71.8 Billion in 2023 and is projected to reach US$122.7 Billion by 2030, growing at a CAGR of 8.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth of nanotechnology in drug delivery is driven by several key factors. Technological advancements in nanoparticle fabrication and nanoscale imaging have significantly broadened the applications and effectiveness of nanomedicines. Increased regulatory support and dedicated funding are accelerating the development and approval of innovative nanotechnology applications, supporting research that spans across various diseases and medical challenges. Moreover, the shift towards patient-centric healthcare underscores the demand for drug delivery systems that enhance patient compliance and quality of life. Nanotechnologies offer customized and less invasive treatment options that align with modern healthcare goals of reducing treatment durations and improving therapeutic outcomes. Additionally, collaborations across diverse scientific disciplines are propelling forward the capabilities of nanotechnologies, integrating insights from materials science, chemistry, biology, and pharmaceutical sciences to innovate and refine drug delivery systems. As global health challenges evolve, the flexibility and adaptability of nanotechnologies to address emerging public health concerns like antibiotic resistance and pandemic responses become increasingly crucial, promising a future where nanotechnology plays a pivotal role in advancing drug delivery and patient care.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Nanoparticles segment, which is expected to reach US$35.6 Billion by 2030 with a CAGR of a 8.2%. The Liposomes segment is also set to grow at 8.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $18.8 Billion in 2023, and China, forecasted to grow at an impressive 11.8% CAGR to reach $30.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nanotechnology in Drug Delivery Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nanotechnology in Drug Delivery Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nanotechnology in Drug Delivery Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as AbbVie Inc., Aquanova AG, BlueWillow Biologics, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 36 Featured):

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Nanotechnology in Drug Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Expands Addressable Market for Nanomedicine
  • Advances in Nanoscale Engineering Drive Innovations in Drug Delivery Mechanisms
  • Increasing Investment in Biotechnology Research Strengthens Business Case for Nanotechnology
  • Personalized Medicine Trends Generate Demand for Nanotechnology-Enabled Drug Delivery
  • Global Health Challenges Catalyze Development of Novel Nanotherapeutics
  • Patent Expirations of Blockbuster Drugs Throw Spotlight on Nanodelivery as a Differentiation Strategy
  • Collaborations Between Pharma and Nanotech Companies Enhance Drug Efficacy and Safety
  • Technological Convergence Spurs Integrated Solutions in Nanotechnology and Drug Delivery
  • Aging Population and Associated Health Needs Drive Nanotechnology Applications
  • Market Entry of Startups Introduces Disruptive Innovations in Nanodelivery Systems
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Nanotechnology in Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Nanocrystals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Nanocrystals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Nano Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Nano Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Anti-Inflammatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 24: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: USA 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: Canada 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Canada 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
JAPAN
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 34: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Japan 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
CHINA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 36: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: China 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 38: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
EUROPE
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 40: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 41: Europe 7-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2024 & 2030
  • Table 42: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Europe 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
FRANCE
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 46: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: France 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 48: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: France 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
GERMANY
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 50: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Germany 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 52: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Germany 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
ITALY
  • Table 54: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Italy 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 56: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Italy 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
UNITED KINGDOM
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 58: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: UK 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 60: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: UK 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
SPAIN
  • Table 62: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Spain 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 64: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Spain 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
RUSSIA
  • Table 66: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Russia 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 68: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Russia 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
REST OF EUROPE
  • Table 70: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Rest of Europe 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 72: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: Rest of Europe 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
ASIA-PACIFIC
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 75: Asia-Pacific 7-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2024 & 2030
  • Table 76: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 77: Asia-Pacific 7-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2024 & 2030
  • Table 78: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 79: Asia-Pacific 7-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2024 & 2030
AUSTRALIA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

Table Information